Steve Saviuk, Valeo Pharma (CSE:VPH)

Published: Feb. 21, 2021, 7:22 a.m.

Agoracom interviews CEOs of small cap companies. In this episode of the Small Cap CEO Interviews podcast, AGORACOM speaks with Valeo Pharma (CSE:VPH) CEO, Steve Saviuk. Valeo Pharma Hesperco™ Capsules at core of Montreal Heart Institute’s coronavirus clinical trial. Download This Episode View Company Website Visit Investor Relations Hub